SCHEMBL23770787

SCHEMBL23770787

Cc1ccccc1-c1nc(N[S+]([O-])c2cccc(N3CCCC3)n2)ccc1C(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.35
NPY5R Q15761 1/20 0.34
KDM4E B2RXH2 5/20 0.33
ALDH1A1 P00352 3/20 0.33
HSD17B10 Q99714 3/20 0.33
TDP1 Q9NUW8 3/20 0.33
CYP1A2 P05177 2/20 0.33
TSHR P16473 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
GBA1 P04062 1/20 0.33
CNR2 P34972 2/20 0.32
TACR1 P25103 2/20 0.32
CYP2C9 P11712 1/20 0.31
HPGD P15428 2/20 0.31
NPSR1 Q6W5P4 1/20 0.31
USP2 O75604 1/20 0.31
LMNA P02545 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770621 0.99 PDE10A (0.35) PDE10ANPY5RKDM4EALDH1A1HSD17B10
SCHEMBL23770416 0.89 PTPN11 (0.37) MAPK1
SCHEMBL23770712 0.88 NPC1 (0.33) KDM4EALDH1A1HSD17B10TDP1CYP1A2
SCHEMBL23770634 0.87 CYP1A2 (0.34) CYP1A2CYP2C19CYP2C9
SCHEMBL23770649 0.87 PIM1 (0.34) CYP1A2TSHRCYP2D6
SCHEMBL23770480 0.87 GRIN2B (0.33)
SCHEMBL23770748 0.86 RORC (0.33) TACR1
SCHEMBL23770464 0.86 LMNA (0.34) KDM4EALDH1A1GBA1TACR1LMNA
SCHEMBL23770448 0.85 CKS1B (0.40) LMNA
SCHEMBL23770823 0.82 CYP1A2 (0.38) ALDH1A1HSD17B10CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed